New Zealand Blood Service

What New Zealand Blood Service does

New Zealand Blood Service (NZBS) is a Crown entity established by the Health Amendment Act 1998 that operates as the sole national provider of blood, plasma, and related biological products in New Zealand. The organisation collects whole blood, plasma, and platelets from voluntary unpaid donors at ten fixed donor centres across the North and South Islands supplemented by mobile blood drives, then processes, tests, and distributes these components along with fractionated plasma-derived products including immunoglobulins (IVIg and SCIg), albumin, and coagulation factors. Plasma fractionation itself is conducted by CSL Behring under a strategic partnership, with finished products flowing back through District Health Boards (DHBs). NZBS directly manages blood banks at six of the country's largest hospitals, performs the majority of national pretransfusion testing, and runs the New Zealand Transplantation and Immunogenetics Laboratory supporting haematopoietic cell and solid organ transplant programs.

The core technology stack centres on apheresis equipment for plateletpheresis and plasmapheresis, blood component separation and testing workflows, and supporting digital infrastructure including the NZBS Donor App (available on Android and iOS) and website-based booking, with data hosted on Microsoft Azure in Australia. Clinical services extend to therapeutic apheresis, therapeutic venesection (including for haemochromatosis), patient blood management, immunohaematology reference laboratory services, a Transfusion Medicine Handbook for clinicians, and the haemovigilance programme that monitors adverse transfusion events.

NZBS is government-funded rather than commercially priced: blood donation is voluntary and unpaid, and products are supplied to DHBs and ultimately to patients through the public health system with no direct patient charges. The go-to-market combines a community-led donor recruitment motion (public campaigns, National Blood Donor Week, media partnerships including MediaWorks/ZM radio, and the October 2025 appointment of Remade as lead creative partner) with a direct-to-consumer digital booking layer. Customer concentration is effectively total: every revenue dollar flows through the New Zealand public healthcare system via DHBs. Recent strategic activity has focused on expanding plasma collection capacity, rolling out the IgO immunoglobulin prescribing system across additional DHBs, and broadening the physical donor centre footprint.

Name

New Zealand Blood Service

Legal name

New Zealand Blood Service

Website

https://nzblood.co.nz

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

501–1,000 employees

Short description

New Zealand Blood Service is the statutory national monopoly provider of blood, plasma, and related biological products in New Zealand, collecting voluntary donations and supplying blood components, immunoglobulins, and coagulation factors to District Health Boards and hospitals across the country.

Ownership category

akta.pro rank

Product category

Blood Banking and Transfusion Services

NAICS

Blood and Organ Banks (621991), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071)

akta.pro primary industry

Transfusion Medicine & Immunohematology (Blood Bank) (HLAFAMAG)

akta.pro secondary industries

Plasma Collection & Donor Services (Plasmapheresis Centers) (HLAIAHAH), Blood, Organ & Tissue Donation Organizations (BPAGACAJ), Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE), Plasma-Derived & Blood Products Distributors (HLAIAJAJ)

Keywords

• Blood collection services
• Plasma donation
• Blood component processing
• Transfusion medicine
• Blood bank services

Headquarters

HQ city

Auckland

HQ country

New Zealand

HQ region

Oceania

Offices7 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Supply Chain, Technology or R&D, Marketing or Sales

Revenue model

1. Blood and Blood Product Supply: NZBS is a Crown entity that collects blood donations and supplies blood components and fractionated blood products to District Health Boards and healthcare providers across New Zealand. The service operates as a government-funded entity providing life-saving blood products to patients.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

New Zealand Blood Service is the national Crown entity responsible for collecting, testing, processing, and supplying blood and blood products across New Zealand. It collects whole blood, plasma, and platelets from voluntary donors through a network of fixed donor centres and mobile drives, then supplies blood components (red cells, platelets, plasma, white cells) and fractionated products (immunoglobulins, coagulation factors, albumin) to District Health Boards and hospitals. It also operates hospital blood banks, provides therapeutic services such as apheresis and venesection, runs the national transplantation immunogenetics laboratory, and maintains haemovigilance and transfusion medicine clinical guidance programmes.

Product overview

New Zealand Blood Service (NZBS) operates as a national blood service providing comprehensive blood and plasma collection, testing, processing, and distribution services. The organisation offers whole blood, plasma, and platelet donation programs through fixed donor centres and mobile blood drives across New Zealand. For healthcare professionals, NZBS provides a wide range of blood components (red cells, platelets, plasma, white cells), fractionated products (immunoglobulins including IVIg and SCIg, coagulation factors, albumin), and clinical services including Blood Banks in major hospitals, Reference Laboratory services, Therapeutic Services (apheresis, venesection), and the New Zealand Transplantation and Immunogenetics Laboratory. The NZBS Donor App enables donors to book appointments. Additional services include Haemovigilance Programme monitoring, Anticoagulant Reversal clinical guidance, Transfusion Medicine Handbook resources, and patient information series.

Differentiator

Problem solved

Functional benefit

Products and services

• Blood Donation Services

Named customers3 records

Segments4 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• RemadecoreGTM or Marketing Partner · 28 October 2025Remade appointed as lead creative partner to promote blood and plasma donation. The partnership includes launching a new donor centre and a nationwide plasma campaign to increase community participation in blood donation.
• CSL BehringcoreStrategic or Co-development PartnerCSL Behring fractionates NZBS plasma donations into protein concentrates and blood products including immunoglobulins (Privigen, Hizentra, IntragamP), albumin solutions (Alburex), and coagulation factors (Beriplex, RiaSTAP, FIBROGAMMIN). CSL Behring is changing manufacturing processes affecting product availability.
• District Health BoardscoreStrategic or Co-development PartnerNZBS provides blood banking services and blood products to all District Health Boards across New Zealand. The service manages blood banks in six major DHB hospitals and provides clinical guidelines and haemovigilance reporting.
• MediaWorksminorGTM or Marketing PartnerMedia partnership for Blood Buddies winter campaign featuring NZBS content through MediaWorks radio and digital platforms (ZM radio station).
• Auckland DHBcoreStrategic or Co-development PartnerOne of six DHBs where NZBS manages the blood bank and provides Privigen and other IVIG products.
• Auckland DHBcoreStrategic or Co-development PartnerIgO (Immunoglobulin Online) approval system rolled out for Bay of Plenty, Auckland, Waikato, MidCentral, Capital & Coast, Canterbury and Southern DHBs for intravenous and subcutaneous immunoglobulin prescribing.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Australian Red Cross Lifeblood: Australia's national blood collection, processing, and distribution service. Most directly comparable peer to NZBS given shared regional context, similar statutory role, comparable voluntary donor model, and overlapping plasma fractionation arrangements.
• NHS Blood and Transplant (NHSBT): UK national blood and transplantation service operating a comparable model of voluntary donor collection, component processing, hospital blood bank management, and therapeutic services. Closest international analogue to NZBS in scope and governance structure.
• Canadian Blood Services: Canada's national, not-for-profit blood operator responsible for collecting, testing, and distributing blood and plasma products. Comparable mandate to NZBS in serving a national healthcare system with voluntary unpaid donors.
• American Red Cross Blood Services: Operates the largest blood collection network in the United States, supplying about 40% of the U.S. blood supply. Comparable end-to-end blood service operations including collection, processing, testing, and hospital distribution.
• Irish Blood Transfusion Service: Ireland's national blood service providing whole blood, platelet, and plasma collection plus hospital transfusion laboratory services. Comparable scale, statutory mandate, and donor-funded operating model to NZBS.
• European Blood Alliance: Association of European national blood services that share comparable voluntary donor-based operating models, regulatory frameworks, and clinical transfusion medicine functions similar to NZBS.
• South African National Blood Service (SANBS): South Africa's national blood service operating voluntary donor collection, processing, and hospital supply with a statutory mandate similar to NZBS, although in a markedly larger and more complex healthcare market.

Regional players

• Singapore Blood Services (Health Sciences Authority): Singapore's national blood service operates under the Health Sciences Authority and provides comparable donor recruitment, blood component preparation, and hospital distribution services within a similarly sized national health system.

Broad incumbents

• CSL Behring: Global plasma fractionator and NZBS's manufacturing partner for plasma-derived products including immunoglobulins, albumin, and coagulation factors. Comparable as it processes plasma into finished therapies but operates at much larger scale as a commercial pharmaceutical company.
• Octapharma: Major global manufacturer of plasma-derived medicines (immunoglobulins, coagulation factors, albumin). Comparable to NZBS's downstream operations as it produces finished plasma products from collected plasma.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/nzblood
• Facebookfacebook.com/NewZealandBloodService

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about New Zealand Blood Service